RxNorm Semantic Concepts Index - 356
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "356".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 35601 | Phosphoribulose epimerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35601 | Phosphoribulose epimerase | Designated preferred name (PT) | NO | |
| RxCUI: 35601 | Phosphoribulose epimerase | Full form of descriptor (FN) | NO | |
| RxCUI: 35605 | ricinoleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 35607 | RID | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 35616 | rifamycin SV | Full form of descriptor (FN) | YES | |
| RxCUI: 35616 | rifamycin SV | Full form of descriptor (FN) | YES | |
| RxCUI: 35616 | rifamycin SV | Designated preferred name (PT) | YES | |
| RxCUI: 35616 | rifamycin SV | Full form of descriptor (FN) | YES | |
| RxCUI: 35616 | rifamycin SV | Designated preferred name (PT) | YES | |
| RxCUI: 35616 | rifamycin SV | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 35616 | rifamycin SV | Designated preferred name (PT) | YES | |
| RxCUI: 35617 | rifapentine | Full form of descriptor (FN) | YES | |
| RxCUI: 35617 | rifapentine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 35617 | rifapentine | Designated preferred name (PT) | YES | |
| RxCUI: 35617 | rifapentine | Full form of descriptor (FN) | YES | |
| RxCUI: 35617 | rifapentine | Designated preferred name (PT) | YES | |
| RxCUI: 35619 | rifaximin | Full form of descriptor (FN) | YES | |
| RxCUI: 35619 | rifaximin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 35619 | rifaximin | Designated preferred name (PT) | YES | |
| RxCUI: 35619 | rifaximin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 35619 | rifaximin | Full form of descriptor (FN) | YES | |
| RxCUI: 35619 | rifaximin | Designated preferred name (PT) | YES | |
| RxCUI: 35623 | Riluzole | Full form of descriptor (FN) | YES | |
| RxCUI: 35623 | Riluzole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 35623 | Riluzole | Designated preferred name (PT) | YES | |
| RxCUI: 35623 | Riluzole | Full form of descriptor (FN) | YES | |
| RxCUI: 35623 | Riluzole | Designated preferred name (PT) | YES | |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Full form of descriptor (FN) | YES | |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Designated preferred name (PT) | YES | |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Full form of descriptor (FN) | YES | |
| RxCUI: 35636 | 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-A)pyrimidin-4-one | Designated preferred name (PT) | YES | |
| RxCUI: 3565 | Suxamethonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 3565 | Suxamethonium chloride | Designated preferred name (PT) | YES | |
| RxCUI: 3565 | Suxamethonium chloride | Full form of descriptor (FN) | YES | |
| RxCUI: 3565 | Suxamethonium chloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 35659 | Ribonucleic acid-3'-phosphate cyclase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35659 | Ribonucleic acid-3'-phosphate cyclase | Full form of descriptor (FN) | NO | |
| RxCUI: 35659 | Ribonucleic acid-3'-phosphate cyclase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35659 | Ribonucleic acid-3'-phosphate cyclase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35659 | Ribonucleic acid-3'-phosphate cyclase | Designated preferred name (PT) | NO | |
| RxCUI: 3567 | Diuretic | Designated preferred name (PT) | NO | |
| RxCUI: 3567 | Diuretic | Full form of descriptor (FN) | NO | |
| RxCUI: 3567 | Diuretic | Designated preferred name (PT) | NO | |
| RxCUI: 3567 | Diuretic | Full form of descriptor (FN) | NO | |
| RxCUI: 356726 | Plenaxis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 356728 | UroXatral | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356733 | Velcade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356739 | Alvesco | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356743 | Fuzeon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356761 | Fosrenol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356766 | Zavesca | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356767 | Xolair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356771 | Somavert | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356772 | Noxafil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356773 | pramlintide acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 356773 | pramlintide acetate | Designated preferred name (PT) | YES | |
| RxCUI: 356773 | pramlintide acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 356774 | Symlin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356778 | Ranexa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 3568 | Mercurial diuretic | Designated preferred name (PT) | NO | |
| RxCUI: 3568 | Mercurial diuretic | Full form of descriptor (FN) | NO | |
| RxCUI: 356834 | deracoxib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 356834 | deracoxib | Designated preferred name (PT) | YES | |
| RxCUI: 356834 | deracoxib | Full form of descriptor (FN) | YES | |
| RxCUI: 356834 | deracoxib | Designated preferred name (PT) | YES | |
| RxCUI: 356834 | deracoxib | Full form of descriptor (FN) | YES | |
| RxCUI: 356884 | Levitra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356886 | Oxytrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 356887 | levocetirizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 356887 | levocetirizine | Designated preferred name (PT) | YES | |
| RxCUI: 356887 | levocetirizine | Full form of descriptor (FN) | YES | |
| RxCUI: 356887 | levocetirizine | Designated preferred name (PT) | YES | |
| RxCUI: 356887 | levocetirizine | Full form of descriptor (FN) | YES | |
| RxCUI: 3569 | Osmotic diuretic | Designated preferred name (PT) | NO | |
| RxCUI: 3569 | Osmotic diuretic | Full form of descriptor (FN) | NO | |
| RxCUI: 356988 | efalizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 356988 | efalizumab | Designated preferred name (PT) | NO | |
| RxCUI: 356988 | efalizumab | Full form of descriptor (FN) | NO | |
| RxCUI: 356988 | efalizumab | Designated preferred name (PT) | NO | |
| RxCUI: 356988 | efalizumab | Full form of descriptor (FN) | NO |